Canine Vomiting: When to Induce Emesis and Contraindications

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Induction of emesis in dogs is a risk-benefit calculation, with a general time window of 2-4 hours post-ingestion, but this narrows for rapidly absorbed toxins and widens for large, poorly soluble materials.
• Contraindications to emesis include ingestion of caustic/corrosive agents, petroleum distillates, substances causing rapid seizures, or patients with compromised mentation, airway integrity, or significant cardiac/esophageal disease.
• Ropinirole eye drops demonstrate high efficacy (95% in a clinical study) and a favorable safety profile for owner administration under veterinary supervision, while apomorphine offers rapid in-hospital induction but carries risks of CNS and respiratory depression.
• Hydrogen peroxide is a variable, gastric-irritating emetic with non-trivial risks of gastritis and aspiration, best reserved for situations where no safer pharmacological alternatives are available.
• Aspiration pneumonia is the most serious complication, necessitating continuous respiratory monitoring and prompt intervention; other risks include esophageal injury, protracted vomiting, and CNS depression.
• Documentation of the ingested substance, time, patient status, contraindications, emetic agent used, and response is critical for clinical continuity and medicolegal defense.

This article provides a clinical decision framework for the induction of emesis in dogs, written for practicing veterinarians and veterinary students. It addresses the procedural question of when gastric decontamination by induced vomiting is indicated, when it is contraindicated, and how to select among available emetic techniques. The content assumes familiarity with canine physiology and toxicology and does not cover owner-administered home remedies.

The decision to induce vomiting in a poisoned or otherwise exposed dog requires weighing the potential benefit of removing gastric contents against the risks of aspiration, trauma to the esophagus or stomach, and delayed administration of definitive therapy. This article presents the physiological basis of emesis, the evidence for currently available emetic agents, and a structured approach to case selection. Related topics, including diagnostic workup of the vomiting patient and antiemetic selection, are covered in companion articles.

At a Glance

Physiology of the Emetic Reflex

Vomiting in dogs is coordinated by the vomiting center, a network of nuclei in the medulla that integrates afferent input from four principal sources: the chemoreceptor trigger zone (CRTZ), the gastrointestinal tract via vagal and sympathetic afferents, the vestibular apparatus, and higher cortical centers. The CRTZ lies outside the blood-brain barrier and responds to circulating emetogenic substances, which makes it the primary target for systemically administered emetic drugs. Vagal afferents from the stomach and proximal small intestine respond to distension, irritation, and specific chemical stimuli, providing a second route for toxin detection.

The motor act of vomiting involves coordinated contraction of the diaphragm and abdominal musculature, relaxation of the lower esophageal sphincter, and closure of the glottis to protect the airway. This coordination is mediated by efferent pathways through the phrenic, spinal, and vagal nerves. The presence of food in the stomach delays gastric emptying and prolongs the window during which emesis can retrieve ingested material. Conversely, an empty stomach may reduce the likelihood of successful emesis and increase the risk of retching without productive vomiting.

Pharmacological Basis of Emetic Agents

Dopamine D2 Receptor Agonists

Apomorphine and ropinirole both act as agonists at dopamine D2 receptors in the CRTZ. Apomorphine has a long history of use in canine practice and can be administered by subcutaneous, intramuscular, or conjunctival routes. Its efficacy is well established, but it carries a risk of prolonged emesis, central nervous system depression, and, in some cases, respiratory depression. Ropinirole, a newer option, is formulated as an ophthalmic solution and has been evaluated in a randomised, double-blind, placebo-controlled clinical study. In that study, ropinirole eye drops induced vomiting in 95% of treated dogs within 30 minutes, with a median time to first vomit of 10 minutes and no vomiting in the placebo group. The same study reported that all owners were able to administer the product and that observed ocular signs were transient and mild. These findings support ropinirole as a reliable, owner-administered emetic under veterinary supervision.

Alpha-2 Adrenergic Agonists

Xylazine is an alpha-2 adrenergic agonist with emetic properties in dogs, though its use is more common in cats. It produces emesis through central alpha-2 receptor activation, but its sedative and hypotensive effects limit its appeal in the poisoned patient, where mentation and perfusion are already at risk. It is not considered a first-line agent in most canine poisoning scenarios.

Hydrogen Peroxide

Oral hydrogen peroxide (3% solution) is widely used in general practice and by owners, though it is not approved for this purpose by regulatory bodies. Its mechanism involves direct gastric irritation and generation of oxygen gas, which distends the stomach and stimulates vagal afferents. Efficacy is variable, and the risk of gastritis, esophagitis, and aspiration pneumonia is non-trivial. The MSD Veterinary Manual notes that hydrogen peroxide is not a reliable emetic and that its use should be weighed against safer pharmacological alternatives. Given the availability of ropinirole and apomorphine, hydrogen peroxide is best reserved for situations where no other option exists.

Evidence Base and Knowledge Gaps

The evidence supporting specific emetic agents in dogs is limited to a small number of clinical trials and a larger body of extrapolated data from other species. The ropinirole study cited above is the only recent randomised controlled trial of an emetic agent in client-owned dogs. Data on apomorphine efficacy derive largely from older studies and clinical experience. The ACVIM consensus statements provide expert guidance on toxicology and gastrointestinal disease, but they do not currently offer a dedicated consensus on emesis induction.

Comparative data from other species are instructive but not directly transferable. A narrative review of the emetic PP796, added to paraquat formulations to induce early vomiting in humans, found no published primary data on its effectiveness despite decades of mandated use. This highlights a broader problem in emetic research: agents are often adopted into practice on the basis of mechanistic plausibility and anecdotal success instead of rigorous clinical trials. The same review noted that pre-clinical dog studies were part of the unpublished company data, but the absence of peer-reviewed evidence limits confidence in extrapolating those findings to clinical canine practice.

Studies in ferrets and squirrel monkeys have examined radiation- and motion-induced vomiting, respectively, and have contributed to understanding of emetic pathways and habituation. These models are useful for studying the physiology of vomiting but do not provide direct evidence for the efficacy of pharmacological emetics in dogs. Clinicians should therefore interpret the available evidence with appropriate caution and rely on clinical judgment when selecting an agent.

Decision Framework for Emesis Induction

The decision to induce vomiting rests on three sequential questions. First, is the ingested substance potentially harmful? Second, is it still in the stomach? Third, can the patient safely vomit? Each question is addressed in detail in the companion article on indications for inducing emesis. The present article focuses on the physiological and pharmacological foundations that underpin those decisions, as well as the contraindications that override otherwise reasonable indications.

Contraindications to emesis include ingestion of caustic or corrosive substances, petroleum distillates, and agents that cause rapid onset of seizures or coma. In each case, the risk of aspiration or secondary tissue injury exceeds the benefit of gastric emptying. Patients with pre-existing esophageal disease, recent abdominal surgery, or coagulopathies also carry increased risk. The AVMA practice resources and the WOAH terrestrial animal health standards provide broader context on professional standards and animal welfare, though neither addresses emesis induction specifically.

Pre-Procedural Patient Assessment

The decision to induce emesis rests on a time-sensitive risk calculation. Before any emetic is administered, the clinician must confirm three conditions: the ingestion is recent enough for gastric evacuation to be useful, the substance is amenable to removal by vomiting, and the patient can tolerate the physiological stress of emesis.

The useful window for emesis induction is generally 2 to 4 hours after ingestion, though this narrows considerably for rapidly absorbed toxins and widens for large, poorly soluble materials. For most toxins, the probability of meaningful gastric recovery declines sharply after 2 hours. Exceptions include massive ingestions of tablets or capsules, which may remain in the stomach longer, and delayed gastric emptying associated with recent food intake. The clinician should document the estimated time of ingestion, the quantity and formulation of the substance, and the timing of the last meal, since each parameter shifts the risk-benefit calculation.

Patient stability determines whether emesis is safe. Contraindications include:

• Patients with altered mentation, seizures, or loss of gag reflex, because aspiration risk is unacceptably high
• Patients with known or suspected esophageal disease, megaesophagus, or recent esophageal surgery
• Patients with respiratory compromise or dyspnea
• Patients with bleeding disorders or thrombocytopenia, since the act of vomiting can precipitate hemorrhage
• Patients with cardiac disease or arrhythmias, particularly those that could decompensate under vagal stimulation
• Brachycephalic breeds with upper airway obstruction, where increased intrathoracic pressure during vomiting may worsen respiratory status

The gag reflex should be assessed directly instead of assumed. A patient that is dull, ataxic, or recumbent is a poor candidate even if the gag reflex appears intact, because central nervous system depression can progress during the procedure.

Substance-Specific Decision Points

The nature of the ingested material frequently overrides the general time window. Caustic or corrosive substances, including strong acids, alkalis, and concentrated detergents, are absolute contraindications to emesis induction. The emetic will re-expose the esophagus and oropharynx to the corrosive agent, compounding injury. Similarly, petroleum distillates and hydrocarbons carry a high aspiration risk during vomiting, and gastric lavage with airway protection is preferred when intervention is indicated.

Sharp objects, including needles, fishhooks, and glass fragments, may cause perforation during retrograde passage. Endoscopic retrieval is the preferred approach for these materials. Large objects that cannot pass through the gastroesophageal junction should also be removed endoscopically instead of by emesis.

For substances where emesis is indicated, the clinician should verify that the toxin is not already causing clinical signs. Vomiting in a patient that is already symptomatic, particularly with neurologic signs, suggests significant systemic absorption has occurred and gastric evacuation will provide limited benefit while adding risk.

Certain toxins are poorly removed by emesis because they are rapidly absorbed, because they bind to gastric contents, or because they undergo enterohepatic recirculation. The evidence base for emetic efficacy in specific toxicoses is limited, and the clinician should consult current toxicology references when the substance is unfamiliar. The MSD Veterinary Manual provides species-specific guidance on toxin management and emesis decisions.

Emetic Agent Selection

Three pharmacological approaches are available for inducing emesis in dogs: apomorphine, ropinirole, and hydrogen peroxide. The choice depends on the clinical setting, the availability of agents, and the owner's ability to participate in administration.

Apomorphine is a dopamine D2 receptor agonist that acts on the chemoreceptor trigger zone. It can be administered by intravenous, intramuscular, or subconjunctival routes. The intravenous route produces emesis within 1 to 3 minutes, while the subconjunctival route acts within 5 to 10 minutes. Apomorphine is reliable but carries risks of prolonged emesis, central nervous system depression, and, at higher doses, respiratory depression. It is contraindicated in patients with pre-existing cardiac disease.

Ropinirole eye drops represent a newer option. In a randomised, double-blind, placebo-controlled clinical study, ropinirole eye drops induced vomiting in 95% of treated dogs within 30 minutes, with a median time to first vomit of 10 minutes. The same study reported that owners were able to administer the product successfully, with 96% rating administration as easy or very easy. Ocular signs, most commonly hyperaemia, were transient and mild. Ropinirole is a useful option when owner administration is appropriate, but it requires the owner to be calm, capable, and present at the time of the decision. The published clinical study of ropinirole eye drops supports its efficacy and safety profile in the clinical setting.

Hydrogen peroxide is the only agent commonly available in the home environment. It acts as a direct gastric irritant. Its efficacy is variable and dose-dependent, and it carries a risk of gastritis and, in rare cases, gastric ulceration or aspiration pneumonia. The MSD Veterinary Manual advises that hydrogen peroxide should be used only under veterinary direction and that repeated dosing is not recommended if the first dose fails.

Step-by-Step Procedural Checklist

The following sequence applies to in-hospital emesis induction. Owner-administered protocols follow the same logic but require additional instruction and a clear contingency plan.

1. Confirm the indication. Verify the substance, the time since ingestion, and the absence of contraindications.
2. Assess the patient. Record mentation, gag reflex, respiratory effort, and cardiovascular status. Weigh the patient accurately.
3. Position the patient. The dog should be standing or sternally recumbent with the head slightly lowered to facilitate clearance of vomitus. Never place a patient in dorsal recumbency.
4. Administer the emetic. Select the agent based on availability and patient status. For apomorphine, use the lowest effective dose and monitor for response. For ropinirole, apply the drops to the conjunctival sac and avoid touching the cornea.
5. Monitor continuously. Observe for the onset of retching and vomiting. Record the time to first vomit and the number of episodes. Monitor for signs of aspiration, including coughing, dyspnea, or cyanosis.
6. Examine the vomitus. Identify the ingested material when possible. Photograph or document the contents for the medical record. If the expected toxin is not present, consider whether additional gastric evacuation is warranted.
7. Manage the post-emetic period. Offer small amounts of water after vomiting has ceased. Do not feed for 2 to 4 hours. Monitor for persistent vomiting, which may indicate incomplete evacuation or toxin-induced gastroenteritis.
8. Document the procedure. Record the agent, dose, route, time to emesis, number of episodes, vomitus contents, and any adverse events. This documentation supports subsequent clinical decisions and medicolegal review.

Monitoring Parameters and Failure Modes

The primary monitoring parameters during and after emesis induction are respiratory status, cardiovascular stability, and the adequacy of gastric evacuation.

Respiratory monitoring is the highest priority. Aspiration of vomitus is the most serious complication of emesis induction and can occur even in patients with an intact gag reflex. Coughing, tachypnea, or increased respiratory effort during or after vomiting warrants immediate intervention, including oxygen supplementation and thoracic radiography if aspiration is suspected.

Cardiovascular monitoring focuses on heart rate and rhythm. Vagal stimulation during retching can produce bradycardia or, in susceptible patients, arrhythmias. Patients with known cardiac disease should have continuous electrocardiographic monitoring during the procedure.

The adequacy of gastric evacuation is judged by the volume and contents of the vomitus. A single episode that returns the ingested material is sufficient. Repeated vomiting beyond two or three episodes is generally undesirable and may warrant antiemetic therapy. Failure to vomit within 30 minutes of apomorphine or ropinirole administration should prompt reassessment of the dose and the indication, not immediate redosing.

The evidence base for emetic efficacy in dogs is strongest for ropinirole, supported by the randomised controlled trial of ropinirole eye drops. Data for apomorphine and hydrogen peroxide are largely derived from clinical experience and extrapolation from other species. The ACVIM consensus statements provide structured guidance on related gastrointestinal emergencies, though specific recommendations for emesis induction remain limited by the absence of large comparative trials.

Documentation and Communication

The medical record should capture the clinical reasoning behind the decision to induce or withhold emesis. This includes the substance ingested, the estimated quantity, the time of ingestion, the patient's clinical status, and the specific contraindications or indications that influenced the decision. If emesis is withheld, the record should state the rationale and the alternative management plan.

When owner administration is considered, the veterinarian must confirm that the owner can safely handle the patient and the emetic agent. Owners should be instructed to call the clinic immediately if vomiting does not occur within the expected time frame or if the patient shows signs of distress. The AVMA practice resources offer guidance on client communication and emergency preparedness that can be adapted to this context.

Regional differences in drug availability and regulatory status affect the choice of emetic agent. Apomorphine is a controlled substance in some jurisdictions, and ropinirole may not be licensed for veterinary use in all regions. The clinician should verify local regulations and product availability before establishing a practice protocol. The WOAH terrestrial animal health standards address broader animal health and welfare considerations that may apply in production animal settings, though emesis induction is rarely indicated in species other than dogs.

Recognized Complications and Early Detection

Inducing emesis carries inherent risks that can be detected early with structured monitoring. Aspiration pneumonia is the most consequential complication. Early indicators include tachypnoea, increased respiratory effort, crackles on thoracic auscultation, and pyrexia developing within 12 to 72 hours after the procedure. Preoxygenation, positioning the patient in sternal recumbency with the head lowered, and ensuring a patent airway before administration of any emetic agent reduce this risk.

Esophageal injury from caustic or sharp ingesta can occur during vomiting. Hematemesis, dysphagia, ptyalism, or cervical pain on palpation after emesis should prompt thoracic radiography and esophagoscopy. Protracted vomiting beyond the expected duration, defined as more than three episodes after a single emetic dose, risks fluid and electrolyte derangements. Serial assessment of hydration status, packed cell volume, total solids, and serum potassium and sodium concentrations identifies these losses early.

Ocular irritation from ropinirole eye drops is typically transient. Conjunctival hyperaemia was the most common finding in the randomised clinical study of ropinirole, and all observed signs were mild and self-limiting ropinirole eye drops induce vomiting effectively in dogs. Persistent blepharospasm or corneal opacity warrants fluorescein staining and topical lubrication.

Central nervous system signs, including sedation, ataxia, or seizures, may follow alpha-2 agonist administration. These effects are dose dependent and usually resolve without intervention. Prolonged sedation beyond 60 minutes, bradycardia, or hypothermia should be documented and supportive care provided.

Common Errors and Corrective Actions

The most frequent error is inducing emesis without confirming the ingested substance is amenable to gastric retrieval. Corrosives, petroleum distillates, and sharp objects are absolute contraindications. Confirm the substance identity and formulation before proceeding.

A second error is administering an emetic agent to a patient with pre-existing vomiting. Active vomiting indicates the stomach is already emptying, and additional emetic stimulation increases aspiration risk and drug exposure without benefit. Document the absence of vomiting for at least 30 minutes before induction.

Underdosing is common when clinicians extrapolate doses across formulations. Ropinirole is dosed by body surface area, not body weight, and the target dose of 3.75 mg/m² produced vomiting in 95% of treated dogs within 30 minutes in the clinical field study ropinirole eye drops induce vomiting effectively in dogs. Consult a current veterinary formulary for the specific product and concentration.

Failure to monitor after successful emesis is another error. The patient should be observed for at least 60 minutes after the first vomitus to detect ongoing vomiting, respiratory compromise, or incomplete gastric emptying. Radiographic confirmation of gastric content reduction is indicated when the ingested material is radiopaque or when clinical suspicion of incomplete retrieval remains high.

Limitations of Current Evidence

The evidence base for canine emesis induction is uneven. Ropinirole eye drops have the strongest prospective clinical support, with a randomised, double-blind, placebo-controlled field study demonstrating efficacy and safety ropinirole eye drops induce vomiting effectively in dogs. Comparative data against apomorphine or hydrogen peroxide are lacking, and no published trials directly compare these agents.

The emetic PP796, added to paraquat formulations to induce early vomiting and reduce absorption, has no published primary preclinical or clinical effectiveness data. A narrative review of published and unpublished company reports identified this evidence gap evidence for the efficacy of the emetic PP796 in paraquat SL20 formulations. This example illustrates that even mandated emetic additives may lack rigorous public validation.

Expert opinion differs on the threshold for inducing emesis in asymptomatic patients with unknown ingestion times. Some toxicologists recommend induction up to 4 hours post ingestion for most substances, while others extend this window for large meals or delayed gastric emptying. No controlled studies define the optimal time window, and clinical judgment must incorporate substance-specific absorption kinetics.

Escalation and Referral Criteria

Referral to a specialist or emergency facility is warranted when emesis induction fails and the ingested substance has high toxicity, when aspiration is suspected, when esophageal injury is likely, or when the patient deteriorates despite supportive care. Veterinary emergency and critical care specialists can provide advanced airway management, endoscopy for retrieval, and continuous monitoring.

Laboratory involvement is indicated for specific toxicants. Serum concentrations of certain substances, such as ethylene glycol, can confirm exposure and guide antidotal therapy. Clinical pathology support for serial electrolyte, acid-base, and organ function assessment is appropriate when protracted vomiting occurs or when the ingested substance has known organ toxicity.

Regulatory reporting obligations vary by jurisdiction. Suspected adverse drug reactions to emetic agents, particularly those with marketing authorisation, should be reported through the relevant pharmacovigilance system. Suspected foreign animal disease or notifiable intoxication should be reported to the appropriate animal health authority. The WOAH terrestrial animal health standards provide international guidance on notifiable disease reporting, while national authorities define local requirements.

Frequently Asked Questions

What Should I Do When Apomorphine or Ropinirole Is Unavailable?

When standard emetic agents are unavailable, reassess whether emesis is still the correct intervention. If the toxin is rapidly absorbed, corrosive, or a hydrocarbon, deferring emesis is safer than attempting it with an unreliable method. Hydrogen peroxide carries a meaningful risk of gastritis and aspiration, and its efficacy is inconsistent. In a hospital setting, consider gastric lavage under anesthesia with a cuffed endotracheal tube as an alternative, though its benefit declines sharply after 60 to 90 minutes post-ingestion. The MSD Veterinary Manual provides guidance on lavage technique and timing. If neither emesis nor lavage is feasible, shift to gastrointestinal protectants, antiemetics, and supportive care while monitoring for systemic signs.

How Do I Manage Emesis Induction in a Brachycephalic or Dyspnoeic Patient?

Brachycephalic dogs and any patient with respiratory compromise are poor candidates for pharmacologic emesis. Vomiting increases intra-abdominal and intrathoracic pressure, and aspiration risk is elevated in breeds with elongated soft palates or stenotic nares. Pre-oxygenate, place an intravenous catheter, and have suction ready before administering any emetic. If the airway is unstable, skip emesis entirely and pursue gastric lavage under anesthesia. For patients with mild brachycephalic syndrome, ropinirole eye drops may be preferable to apomorphine because the dog remains calmer and less likely to panic, but the same monitoring standards apply. Document the respiratory assessment and the rationale for your chosen approach in the medical record.

What Records Must I Keep After Inducing Emesis?

Document the time of ingestion, the substance and estimated dose, the time of emetic administration, and the time of first vomitus. Record the number of vomition episodes, the character of the vomitus, and whether any toxin fragments were recovered. Note any adverse effects such as prolonged retching, lethargy, or ocular irritation when using ropinirole. Include the patient's pre- and post-procedural vital parameters and any antiemetic administered afterward. If the owner administered the emetic at home under your instruction, record the conversation, the exact instructions given, and the owner's report of events. This record supports both clinical continuity and medicolegal defense if complications arise.

How Should I Advise an Owner Who Wants to Induce Emesis at Home?

Advise owners that emesis induction is a medical procedure with real risks, and that telephone triage cannot replace in-person assessment. Instruct them to call a veterinary clinic before attempting anything, and to bring the toxin container or a photograph of its label. If you judge that home emesis is appropriate, prescribe or dispense ropinirole eye drops instead of recommending hydrogen peroxide, since the randomised clinical study of ropinirole eye drops demonstrated 95% efficacy with transient, mild ocular signs. Give clear instructions on positioning, what to expect within 30 minutes, and when to seek emergency care. Emphasize that inducing emesis for the wrong substance can cause more harm than the ingestion itself.

Does the Decision Framework Differ for Puppies or Geriatric Patients?

Age modifies risk tolerance but not the core decision logic. Puppies have lower body mass, so toxin doses per kilogram are often higher, and they dehydrate faster after vomiting. Their hepatic and renal clearance is immature, which can prolong toxin exposure. Geriatric patients frequently have subclinical cardiac or renal disease that reduces their reserve if vomiting causes electrolyte shifts or vagal events. In both groups, err toward hospitalization and intravenous fluid support after emesis. The ACVIM consensus statements offer species-specific guidance on supportive care thresholds. Calculate toxin dose per kilogram carefully in small patients, since a single tablet can exceed the toxic threshold.

How Do I Explain a Decision Not to Induce Emesis to a Client?

Lead with the specific reason: the substance is corrosive, the time window has passed, or the patient has a contraindication. Explain that vomiting would expose the esophagus and airway to the same damaging agent a second time, and that the goal is to protect, not to punish. Use the analogy of a chemical burn: you would not scrub it, you would rinse and protect it. Describe the alternative plan concretely, including activated charcoal, antiemetics, or hospitalization, so the client leaves with a clear next step. If the client is anxious, acknowledge that doing nothing can feel wrong, and explain that the most dangerous action is the one that harms the airway. Offer a follow-up call within 24 hours to review progress.

Related Clinical & Scientific Guides

• Feline Hepatic Lipidosis: Nutritional and Medical Management
• Canine Respiratory Infection: Diagnostic Approach and Treatment
• Canine Respiratory Virus: Diagnostic and Management Considerations

References and Further Reading

• Evidence for the efficacy of the emetic PP796 in paraquat SL20 formulations - a narrative review of published and unpublished evidence.. 2022.
• Effects of solar particle event proton radiation on parameters related to ferret emesis.. 2013.
• Ropinirole eye drops induce vomiting effectively in dogs: a randomised, double-blind, placebo-controlled clinical study.. 2020.
• Adaptation and habituation of motion-induced vomiting in squirrel monkeys.. 1987.
• Congenital intestinal stenosis and Hirschsprung's disease: two extremely rare pathologies in a newborn puppy.. 2019.
• ACVIM Consensus Statements. Journal of Veterinary Internal Medicine.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Canine Vomiting: Indications for Inducing Emesis
• Canine Vomiting: A Diagnostic and Therapeutic Decision Framework
• Canine Vomiting: Home Management and When to Seek Veterinary Care
• Canine Vomiting: Therapeutic Management and Antiemetic Selection
• Canine Vomiting: When to Refer and Emergency Indicators

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.